Histomorphology and Immunohistochemistry of Gastrointestinal Stromal Tumors in a Malaysian Population

  • Kkrishnappa, Purushotham (Pathology, Medicine, International Medical University) ;
  • Loh, Eu Jhin (Pathology, Medicine, International Medical University) ;
  • Mohamad, Ibtisam Binti (Department of Pathology, Hospital Tuanku Ja'afar) ;
  • Tata, Mahadevan Deva (Department of Surgery, Hospital Tuanku Ja'afar) ;
  • Akhilesh, Meenakshi (Pathology, Medicine, International Medical University) ;
  • Palayan, Kandasami (Department of Surgery, Hospital Tuanku Ja'afar)
  • Published : 2016.06.01

Abstract

Purpose: To study histomorphological and immunohistochemical patterns of gastro-intestinal stromal tumours (GISTs) in Malaysia. Materials and Methods: A total of 29 GIST cases from Hospital Tuanku Ja'afar, Seremban, were studied retrospectively over a period of 10 years from January 2002 to December 2011. Patient demographic data like age, sex and etnicity were collected. Tumour characteristics like site, maximum dimension and specimen type were analysed. Evaluation was according to established criteria into very low, low, intermediate and high-risk categories. Immunohistochemical characteristics were also analysed. Results: The mean age of patients was 59.7 years. Males (59%) were found to be more commonly affected than females (41%). The Chinese (45%) were commonly affected than Malays (41%), and Indians (10%). The most common symptom was pain in the abdomen (13.8%). More than half of the cases were seen in stomach (53%). The tumour size ranged from 1.5 cm to 17 cm with a mean of 6.94cm. Microscopic findings revealed that the spindle cell type was the most common (76%). It was observed that the majority of the cases (48%) were categorised in the intermediate risk group. Immunohistochemical staining showed positivity for CD117 (78.6%), CD34 (71.4%), vimentin (86.2%), S-100 (27.6%), SMA (35.7%), PKC THETA (46.4%) and PDGRFA (67.9%).

Keywords

Gastrointestinal stromal tumor;immunohistochemistry;risk categories;spindle cell;CD 117

References

  1. Allred DC, Harvey JM, Berardo M, et al (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 11, 155-68.
  2. Amin MB, Ma CK, Linden MD, et al (1993). Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumours. Correlation with mitotic count and clinical outcome. Am J Clin Pathol, 4, 428-32.
  3. Daniel R. Perez, Raymond E. Baser, Michael J. Cavnar, et al (2013). Tap et al blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol, 20, 593-9. https://doi.org/10.1245/s10434-012-2682-y
  4. DeMatteo RP, Michael C Heinrich, WA'el M, et al (2002). Clinical management of gastorintestinal stromal tumours: before and after STI-571. Human Pathol, 33, 466-77. https://doi.org/10.1053/hupa.2002.124122
  5. Demetri GD, Benjamin RS, Blanke CD, et al (2007). NCCN Task force report: Management of patients with gastrointestinal stromal tumour (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw, 5, 1-29. https://doi.org/10.6004/jnccn.2007.0001
  6. Fletcher CD, Berman JJ, Corless C, et al (2002). Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 33, 459-65. https://doi.org/10.1053/hupa.2002.123545
  7. Hasegawa T, Matsuno Y, Shimoda T, et al (2002). Gastrointestinal Stromal Tumour: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumour size and MIB-1 grade. Human Pathol, 6, 669-75.
  8. Hirota S, Isozaki K, Moriyama Y, et al (1998). Gain-of-function mutation of c-kit in human gastrointestinal stromal tumours. Science, 279, 577-80. https://doi.org/10.1126/science.279.5350.577
  9. Jiang C, Hu WM, Liao FX, Yang Q, et al (2016). Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients. Onco Targets Therapy, 23, 877-83.
  10. Jin Woong Cho, The Korean ESD Study Group (2016). Current Guidelines in the Management of Upper Gastrointestinal Subepithelial Tumors. Clin Endosc, ce.2015.096.
  11. Khoo JJ, Gunn A (2005). A clinical and immunohistochemical study of gastrointestinal stromal tumours. Malaysian J Pathol, 27, 9-16.
  12. Kim KM, Kang DW, Moon WS, et al (2005). Gastrointestinal stromal tumours in Koreans: its incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci, 20, 977. https://doi.org/10.3346/jkms.2005.20.6.977
  13. Markku Miettinen, Marii Sarlomo-Rikala, Jerzy Lasota (1999). Gastrointestinal stromal tumours: recent advances in understanding of their biology. Human Pathol, 10, 1213-20.
  14. Markku Miettinen, Wa'el El-Rafai, Leslie H Sobin, et al (2002). Evaluation of malignancy and prognosis of gastrointestinal stromal tumours. a review. Human Pathol, 5, 478-83.
  15. Miettinen M, Lasota J (2006). Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol, 23, 70-83. https://doi.org/10.1053/j.semdp.2006.09.001
  16. Steigen SE, Bjerkehagen B, Haugland HK, et al (2008). Diagnostic and prognostic markers of gastrointestinal stromal tumours in Norway. Modern Pathol, 21, 46-53. https://doi.org/10.1038/modpathol.3800976
  17. Y Na Kang, Jung HR, Hwang I (2010). Clinicopathological and immunohistochemical features of gastrointestinal stromal tumours. Cancer Research Treat, 42, 135-43. https://doi.org/10.4143/crt.2010.42.3.135